Study suggests second Pfizer-BioNTech vaccine shot may not be needed after previous SARS-CoV-2 infection
Study suggests second Pfizer-BioNTech vaccine shot may not be needed after previous SARS-CoV-2 infection Researchers in Austria have conducted a study showing that individuals previously infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) exhibit a significantly more pronounced antibody response to one dose of Pfizer-BioNTech’s coronavirus disease 2019 (COVID-19) vaccine than previously uninfected individuals. The team from the Medical University of Vienna says that an astonishing 20- to 100-fold increase in the median antibody level was shown for SARS-CoV-2 seroposit...